Evaluation of the Clinical Impact of Dapagliflozin Discontinuation as Adjunctive Therapy for Patients With Type 1 Diabetes After Indication Withdrawal: A Two-Center Retrospective Study.
José Ignacio Martínez-MontoroMaría José Picón-CésarVíctor José Simón-FrapolliJosé Luis Pinzón-MartínJorge García-AlemánMaría Durán-MartínezFrancisco J TinahonesPublished in: Diabetes care (2023)
Keyphrases